Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Clinical trial NCT01931150 · COMPLETED

Trial details

NCT number: NCT01931150
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cetuximab-induced Papulopustular (Acneiform) Rash Who Have Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma

Start date: 2013-08-01
Primary completion: 2015-09-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.